Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen A Neville

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|December 3, 2009
Busulfan in children: impact of development on dose-exposure-response relationship?Jignesh Dalal, Kathleen A Neville
Current Pharmaceutical Design|October 31, 2015
Pharmacotherapy of Sickle Cell Disease in ChildrenKathleen A Neville, Julie A Panepinto
Cancer Treatment and Research|October 11, 2005
Leptomeningeal cancer in the pediatric patientKathleen A Neville, Susan M Blaney
Drugs|April 10, 2013
Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directionsKeith J August, Aru Narendran, Kathleen A Neville
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|March 11, 2008
Diagnosis of Factor XI deficiency following congenital cataract extractionSrinivas S Iyengar, Scott E Olitsky, Kathleen A Neville
The New England Journal of Medicine|June 24, 2008
Genetics of warfarin responseKathleen A Neville, Brian M Wicklund, Gregory L Kearns
Journal of Pediatric Ophthalmology and Strabismus|July 31, 2015
Developmental Changes of Normal Pupil Size and Reactivity in ChildrenJacob T Brown, Mark Connelly, Caitlin Nickols, et al.
Journal of Clinical Pharmacology|September 9, 2014
Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative painWei Liu, Sandeep Dutta, Greg Kearns, et al.
The Oncologist|February 16, 2006
Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implicationsStephen Bernard, Kathleen A Neville, Anne T Nguyen, et al.
Paediatric Anaesthesia|February 16, 2011
Developmental pharmacogenomicsKathleen A Neville, Mara L Becker, Jennifer L Goldman, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|December 3, 2009
Busulfan in children: impact of development on dose-exposure-response relationship?Jignesh Dalal, Kathleen A Neville
Current Pharmaceutical Design|October 31, 2015
Pharmacotherapy of Sickle Cell Disease in ChildrenKathleen A Neville, Julie A Panepinto
Cancer Treatment and Research|October 11, 2005
Leptomeningeal cancer in the pediatric patientKathleen A Neville, Susan M Blaney
Drugs|April 10, 2013
Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directionsKeith J August, Aru Narendran, Kathleen A Neville
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|March 11, 2008
Diagnosis of Factor XI deficiency following congenital cataract extractionSrinivas S Iyengar, Scott E Olitsky, Kathleen A Neville
The New England Journal of Medicine|June 24, 2008
Genetics of warfarin responseKathleen A Neville, Brian M Wicklund, Gregory L Kearns
Journal of Pediatric Ophthalmology and Strabismus|July 31, 2015
Developmental Changes of Normal Pupil Size and Reactivity in ChildrenJacob T Brown, Mark Connelly, Caitlin Nickols, et al.
Journal of Clinical Pharmacology|September 9, 2014
Pharmacokinetics of hydrocodone/acetaminophen combination product in children ages 6-17 with moderate to moderately severe postoperative painWei Liu, Sandeep Dutta, Greg Kearns, et al.
The Oncologist|February 16, 2006
Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implicationsStephen Bernard, Kathleen A Neville, Anne T Nguyen, et al.
Paediatric Anaesthesia|February 16, 2011
Developmental pharmacogenomicsKathleen A Neville, Mara L Becker, Jennifer L Goldman, et al.
Pageof 3